T964-0316 Screening compound: N-({1-[(4-fluorophenyl)methyl]piperidin-4-yl}methyl)-3-oxo-2-(propan-2-yl)-2-azaspiro[3.4]octane-1-carboxamide

T964-0316 Screening compound: N-({1-[(4-fluorophenyl)methyl]piperidin-4-yl}methyl)-3-oxo-2-(propan-2-yl)-2-azaspiro[3.4]octane-1-carboxamide
T964-0316 Screening compound: N-({1-[(4-fluorophenyl)methyl]piperidin-4-yl}methyl)-3-oxo-2-(propan-2-yl)-2-azaspiro[3.4]octane-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T964-0316
N-({1-[(4-fluorophenyl)methyl]piperidin-4-yl}methyl)-3-oxo-2-(propan-2-yl)-2-azaspiro[3.4]octane-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T964-0316

Molecular Formula

C24H34FN3O2 (C24 H34 FN3 O2)

Compound Name

N-({1-[(4-fluorophenyl)methyl]piperidin-4-yl}methyl)-3-oxo-2-(propan-2-yl)-2-azaspiro[3.4]octane-1-carboxamide

IUPAC name

N-({1-[(4-fluorophenyl)methyl]piperidin-4-yl}methyl)-3-oxo-2-(propan-2-yl)-2-azaspiro[3.4]octane-1-carboxamide

SMILES

CC(C)N(C(C12CCCC2)C(NCC2CCN(Cc(cc3)ccc3F)CC2)=O)C1=O

InChI

InChI=1S/C24H34FN3O2/c1-17(2)28-21(24(23(28)30)11-3-4-12-24)22(29)26-15-18-9-13-27(14-10-18)16-19-5-7-20(25)8-6-19/h5-8,17-18,21H,3-4,9-16H2,1-2H3,(H,26,29)/t21-/m1/s1

InChI Key

ARSAIOJXLCMEDE-OAQYLSRUSA-N

MDL Number (MFCD)

MFCD31982903

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

415.55

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.052

Distribution Coefficient, logD

1.263

Water Solubility, LogSw

-3.22

Polar Surface Area

44.950

Acid Dissociation Constant (pKa)

14.72

Base Dissociation Constant (pKb)

9.18

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

66.67

T964-0316 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T964-0316 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T964-0316?
Check Price and Availability of T964-0316, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T964-0316 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T964-0316
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T964-0316
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T964-0316 available by request